Variable | Route; no. (%) of people | |||
---|---|---|---|---|
Dermal† n = 22 | Ingestion† n = 122 | Inhalation† n = 28 | Total‡ n = 186 | |
Symptoms present | ||||
Yes | 12 (54.5) | 38 (31.1) | 25 (89.3) | 87 (46.8) |
No | 7 (31.8) | 60 (49.2) | 2 (7.1) | 70 (37.6) |
Not recorded | 3 (13.6) | 24 (19.7) | 1 (3.6) | 29 (15.6) |
Symptoms§ | ||||
Local | ||||
Dermal | 4 (18.2) | 0 (0.0) | 1 (3.6) | 5 (2.7) |
Oral/pharyngeal | 0 (0.0) | 7 (5.7) | 1 (3.6) | 9 (4.8) |
Respiratory | 0 (0.0) | 1 (0.8) | 1 (3.6) | 3 (1.6) |
Ocular | 0 (0.0) | 0 (0.0) | 0 (0.0) | 11 (5.9) |
Vaginal | 0 (0.0) | 0 (0.0) | 0 (0.0) | 1 (0.5) |
Systemic | ||||
Not typical for nicotine exposure | 4 (18.2) | 19 (15.6) | 11 (39.3) | 45 (24.2) |
Typical for low nicotine exposure | 8 (36.4) | 18 (14.8) | 15 (53.6) | 42 (22.6) |
Typical for high nicotine exposure | 0 (0.0) | 2 (1.6) | 0 (0.0) | 2 (1.1) |